Table of Content

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Radiopharmaceutical Theranostics Market – by Product Type
1.3.2 North America Radiopharmaceutical Theranostics Market – by Radioisotope
1.3.3 North America Radiopharmaceutical Theranostics Market – by Source
1.3.4 North America Radiopharmaceutical Theranostics Market – by Application
1.3.5 North America Radiopharmaceutical Theranostics Market – by Indication
1.3.6 North America Radiopharmaceutical Theranostics Market – by End User
1.3.7 North America Radiopharmaceutical Theranostics Market – by Country

2. North America Radiopharmaceutical Theranostics Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Radiopharmaceutical Theranostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Experts’ Opinion

5. Radiopharmaceutical Theranostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Cancer
5.1.2 Rising Application in Treatment of Cardiovascular Disorders
5.2 Market Restraints
5.2.1 Regulatory Challenges for Approval of Radiopharmaceutical Theranostics
5.3 Market Opportunities
5.3.1 Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies
5.4 Future Trends
5.4.1 Radiopharmaceutical Theranostics in Nuclear Medicine
5.5 Impact Analysis

6. North America Radiopharmaceutical Theranostics Market Analysis
6.1 North America Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis
6.1.1 Market Positioning of Key Players in Radiopharmaceutical Theranostics Market
6.1.1.1 GE HealthCare Technologies Inc
6.1.1.2 Curium

7. North America Radiopharmaceutical Theranostics Market Analysis – by Product Type
7.1 Overview
7.1.1 Alpha Emitters
7.1.1.1 Overview
7.1.1.2 Alpha Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
7.1.2 Beta Emitters
7.1.2.1 Overview
7.1.2.2 Beta Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
7.1.3 Positron Emission Tomography (PET) Tracers
7.1.3.1 Overview
7.1.3.2 Positron Emission Tomography (PET) Tracers: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Radiopharmaceutical Theranostics Market Analysis – by Radioisotope
8.1 Overview
8.1.1 Technetium-99
8.1.1.1 Overview
8.1.1.2 Technetium-99: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.2 Gallium-68
8.1.2.1 Overview
8.1.2.2 Gallium-68: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.3 Iodine-131
8.1.3.1 Overview
8.1.3.2 Iodine-131: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.4 Iodine-123
8.1.4.1 Overview
8.1.4.2 Iodine-123: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.5 Fluorine-18 (18F)
8.1.5.1 Overview
8.1.5.2 Fluorine-18 (18F): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.6 Yttrium-90 (Y-90)
8.1.6.1 Overview
8.1.6.2 Yttrium-90 (Y-90): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.7 Lutetium (Lu) 177
8.1.7.1 Overview
8.1.7.2 Lutetium (Lu) 177: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.8 Copper (Cu) 67
8.1.8.1 Overview
8.1.8.2 Copper (Cu) 67: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.9 Copper (Cu) 64
8.1.9.1 Overview
8.1.9.2 Copper (Cu) 64: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.10 Others
8.1.10.1 Overview
8.1.10.2 Others: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Radiopharmaceutical Theranostics Market Analysis – by Source
9.1 Overview
9.1.1 Nuclear Reactors
9.1.1.1 Overview
9.1.1.2 Nuclear Reactors: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2 Cyclotrons
9.1.2.1 Overview
9.1.2.2 Cyclotrons: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)

10. North America Radiopharmaceutical Theranostics Market Analysis – by Application
10.1 Overview
10.1.1 Targeted Therapeutic (Rx)
10.1.1.1 Overview
10.1.1.2 Targeted Therapeutics (Rx): North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2 Companion Diagnostic (CDx)
10.1.2.1 Overview
10.1.2.2 Companion Diagnostics (CDx): North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)

11. North America Radiopharmaceutical Theranostics Market Analysis – by Indication
11.1 Overview
11.1.1 Oncology
11.1.1.1 Overview
11.1.1.2 Oncology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2 Neurology
11.1.2.1 Overview
11.1.2.2 Neurology: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3 Cardiology
11.1.3.1 Overview
11.1.3.2 Cardiology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.4 Others
11.1.4.1 Overview
11.1.4.2 Others: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)

12. North America Radiopharmaceutical Theranostics Market Analysis – by End User
12.1 Overview
12.1.1 Hospitals
12.1.1.1 Overview
12.1.1.2 Hospitals: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
12.1.2 Diagnostic Imaging Centers
12.1.2.1 Overview
12.1.2.2 Diagnostic Imaging Centers: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3 Academic & Research Institutes
12.1.3.1 Overview
12.1.3.2 Academic & Research Institutes: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
12.1.4 Others
12.1.4.1 Overview
12.1.4.2 Others: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
13. North America Radiopharmaceutical Theranostics Market
13.1 Overview
13.1.1 North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2 North America: Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.1.3 North America: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.1.4 North America: Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)0
13.1.5 North America: Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)0
13.1.6 North America: Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)1
13.1.7 North America: Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)1
13.1.7.1 United States: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)3
13.1.7.1.1 Overview3
13.1.7.1.2 United States Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)4
13.1.7.1.3 United States Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)5
13.1.7.1.4 United States Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)6
13.1.7.1.5 United States Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)7
13.1.7.1.6 United States Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)7
13.1.7.1.7 United States Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)8
13.1.7.1.8 United States Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)8
13.1.7.2 Canada: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)9
13.1.7.2.1 Overview9
13.1.7.2.2 Canada Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)0
13.1.7.2.3 Canada Radiopharmaceutical Theranostics Market, by Product type, 2019–2028 (US$ Million)1
13.1.7.2.4 Canada Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)2
13.1.7.2.5 Canada Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)3
13.1.7.2.6 Canada Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)3
13.1.7.2.7 Canada Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)4
13.1.7.2.8 Canada Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)4
13.1.7.3 Mexico: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)5
13.1.7.3.1 Overview5
13.1.7.3.2 Mexico Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)6
13.1.7.3.3 Mexico Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)7
13.1.7.3.4 Mexico Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)8
13.1.7.3.5 Mexico Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)9
13.1.7.3.6 Mexico Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)9
13.1.7.3.7 Mexico Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)0
13.1.7.3.8 Mexico Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)1

14. North America Radiopharmaceutical Theranostics Market: Impact Assessment of COVID-19 Pandemic2
14.1 Impact Analysis of COVID-19 Pandemic on North America Radiopharmaceutical Theranostics Market2

15. North America Radiopharmaceutical Theranostics Market – Industry Landscape5
15.1 Overview5
15.2 Growth Strategies in North America Radiopharmaceutical Theranostics Market (%)6
15.3 Organic Developments7
15.3.1 Overview7
15.4 Inorganic Developments1
15.4.1 Overview1

16. Company Profiles5
16.1 Bayer AG5
16.1.1 Key Facts5
16.1.2 Business Description5
16.1.3 Products and Services6
16.1.4 Financial Overview7
16.1.5 SWOT Analysis0
16.1.6 Key Developments1
16.2 GE HealthCare Technologies Inc2
16.2.1 Key Facts2
16.2.2 Business Description2
16.2.3 Products and Services3
16.2.4 Financial Overview4
16.2.5 SWOT Analysis6
16.2.6 Key Developments7
16.3 Curium9
16.3.1 Key Facts9
16.3.2 Business Description9
16.3.3 Products and Services0
16.3.4 Financial Overview0
16.3.5 SWOT Analysis1
16.3.6 Key Developments2
16.4 Lantheus Medical Imaging, Inc.3
16.4.1 Key Facts3
16.4.2 Business Description3
16.4.3 Products and Services4
16.4.4 Financial Overview4
16.4.5 SWOT Analysis6
16.4.6 Key Developments7
16.5 Telix Pharmaceuticals Ltd.8
16.5.1 Key Facts8
16.5.2 Business Description8
16.5.3 Products and Services9
16.5.4 Financial Overview9
16.5.5 SWOT Analysis1
16.5.6 Key Developments2
16.6 Cardinal Health Inc3
16.6.1 Key Facts3
16.6.2 Business Description3
16.6.3 Products and Services4
16.6.4 Financial Overview4
16.6.5 SWOT Analysis6
16.6.6 Key Developments7
16.7 Advanced Accelerator Applications S.A.8
16.7.1 Key Facts8
16.7.2 Business Description8
16.7.3 Products and Services9
16.7.4 Financial Overview9
16.7.5 SWOT Analysis0
16.7.6 Key Developments1
16.8 Jubilant Radiopharma2
16.8.1 Key Facts2
16.8.2 Business Description2
16.8.3 Products and Services3
16.8.4 Financial Overview3
16.8.5 SWOT Analysis4
16.8.6 Key Developments5
16.9 Theragnostics6
16.9.1 Key Facts6
16.9.2 Business Description6
16.9.3 Products and Services6
16.9.4 Financial Overview6
16.9.5 SWOT Analysis7
16.9.6 Key Developments8
16.10 NuView Life Sciences9
16.10.1 Key Facts9
16.10.2 Business Description9
16.10.3 Products and Services9
16.10.4 Financial Overview0
16.10.5 SWOT Analysis0
16.10.6 Key Developments1

17. Appendix2
17.1 About The Insight Partners2
17.2 Glossary of Terms3



List of Figures

LIST OF FIGURES

Figure 1. Radiopharmaceutical Theranostics Market Segmentation
Figure 2. Radiopharmaceutical Theranostics Market Segmentation, by Region
Figure 3. North America Radiopharmaceutical Theranostics Market Overview
Figure 4. Positron Emission Tomography (PET) Tracers Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market
Figure 5. U.S. to Show Significant Growth in Radiopharmaceutical Theranostics Market During Forecast Period
Figure 6. North America Radiopharmaceutical Theranostics Market – Leading Country Markets (US$ Million)
Figure 7. North America Radiopharmaceutical Theranostics Market, Industry Landscape
Figure 8. North America PEST Analysis
Figure 9. Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints
Figure 10. North America Radiopharmaceutical Theranostics Market – Revenue Forecast and Analysis – 2020–2028
Figure 11. North America Radiopharmaceutical Theranostics Market, by Product Type, 2021 & 2028 (%)
Figure 12. Alpha Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Beta Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Positron Emission Tomography (PET) Tracers: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)
Figure 16. Technetium-99: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Gallium-68: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Iodine-131: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Iodine-123: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Fluorine-18 (18F): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Yttrium-90 (Y-90): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Lutetium (Lu) 177: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Copper (Cu) 67: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Copper (Cu) 64: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)
Figure 27. Nuclear Reactors Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Cyclotrons Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. North America Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)
Figure 30. Targeted Therapeutics (Rx) Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Companion Diagnostics (CDx) Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. North America Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)
Figure 33. Oncology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Neurology Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Cardiology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Others Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. North America Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)
Figure 38. Hospitals Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Diagnostic Imaging Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. Academic & Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 41. Others Market Revenue and Forecasts to 2028 (US$ Million)
Figure 42. North America Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 43. North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. North America Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)0
Figure 45. United States Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)2
Figure 46. Canada Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)8
Figure 47. Mexico Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 48. Impact of COVID-19 Pandemic on North America Markets2
Figure 49. Growth Strategies in North America Radiopharmaceutical Theranostics Market (%)4

List of Tables

LIST OF TABLES

Table 1. North America Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. United States Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)3
Table 8. United States Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)4
Table 9. United States Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)5
Table 10. United States Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)5
Table 11. United States Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)6
Table 12. United States Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)6
Table 13. Canada Radiopharmaceutical Theranostics Market, by Product type – Revenue and Forecast to 2028 (US$ Million)9
Table 14. Canada Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)0
Table 15. Canada Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)1
Table 16. Canada Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)1
Table 17. Canada Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)2
Table 18. Canada Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)2
Table 19. Mexico Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)5
Table 20. Mexico Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)6
Table 21. Mexico Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)7
Table 22. Mexico Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)7
Table 23. Mexico Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)8
Table 24. Mexico Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 25. Organic Developments in the North America Radiopharmaceutical Theranostics Market5
Table 26. Inorganic Developments in the North America Radiopharmaceutical Theranostics Market9
Table 27. Glossary of Terms0